Photochemotherapy using 8-methoxypsoralen (8-MOP) and UVA light may pose risks, but human studies show no ocular damage at therapeutic doses. This review examines safety conditions for photochemotherapy in psoriasis treatment.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: